Cochrane · systematic review · CD012949

Probiotics for people with cystic fibrosis

Coffey, MJ, Garg, M, Homaira, N, et al. · Cochrane Database of Systematic Reviews · 2020 · Cochrane Library

SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 7 · 100%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Probiotics compared to placebo for children and adults with CF

Population: children and adults with CF
7 questions
OutcomeEffectEvidenceStatus / GRADE
Number of pulmonary exacerbations
Probiotics vs placebo
no estimate extracted4 studies · 225 participantsLow
Downgraded: risk of bias, indirectness
Faecal calprotectin
Probiotics vs placebo
no estimate extracted4 studies · 177 participantsLow
Downgraded: risk of bias, indirectness
Adverse events (serious adverse reaction and adverse reaction)
Probiotics vs placebo
RR 3 [0.49, 18.46]5 studies · 310 participantsLow
Downgraded: risk of bias, indirectness
Weight (z score)
Probiotics vs placebo
no estimate extracted2 studies · 91 participantsLow
Downgraded: risk of bias, indirectness
Lung function (FEV1 % predicted)
Probiotics vs placebo
no estimate extracted5 studies · 284 participantsLow
Downgraded: risk of bias, indirectness
Hospitalisations (all causes)
Probiotics vs placebo
no estimate extracted2 studies · 115 participantsLow
Downgraded: risk of bias, indirectness
HRQoL (PedsQLTM 4.0 SF 15 (Scale from: 0 to 100))
Probiotics vs placebo
no estimate extracted1 study · 37 participantsLow
Downgraded: risk of bias, indirectness